Test Price
2,800 AED✅ Home Collection Available
UROD Gene Porphyria Cutanea Tarda (PCT) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين UROD للبورفيريا الجلدية الآجلة (PCT) بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ Accuracy Guarantee
99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing, compliant with Federal Decree‑Law No. 41 of 2024, Art. 87.
🚑 Premium Logistics
Paid hospital‑grade home collection (8 AM – 11 PM) with ISO‑certified cold‑chain transport. VIP mobile phlebotomy available for DNA FTA card, whole blood, or extracted DNA.
📋 Clinical Guidance
Telephonic post‑test clinical interpretation by DHA‑licensed genetic counsellors included. Direct insurance billing verification via WhatsApp: +971 54 548 8731.
الملخص التنفيذي
يُوفِّر هذا الاختبار المعتمَد من هيئة الصحة بدبي تشخيصاً جينياً دقيقاً للبورفيريا الجلدية الآجلة (PCT) عبر الجيل التالي (NGS). الدقة 99.9% مع سحب منزلي مضمون واستشارة طبية لاحقة. التزام صارم بقانون الجينوم البشري الاتحادي رقم 41 لسنة 2024 وحماية بيانات المرضى.
Test Overview
The UROD gene NGS test sequences the entire coding region of the uroporphyrinogen decarboxylase gene to detect pathogenic variants linked to porphyria cutanea tarda (PCT). يُساعِد تحليل جين UROD في تأكيد التشخيص وتقييم خطر المرض لدى الأقارب. This test differentiates familial PCT (type II) from acquired/sporadic forms, guiding targeted management and family screening.
| Feature | Our Test (DHA Approved) | Closest Alternative |
|---|---|---|
| Precision | Full gene NGS (>99% sensitivity) | Targeted mutation panels (limited) |
| Methodology | Illumina‑based NGS with Sanger confirmation | Sanger only for known variants |
| Turnaround Time | 3‑4 Weeks (express available) | 4‑6 Weeks overseas |
| UAE Compliance | Full DHA/MOHAP, PDPL, 2024 Genomic Law | May not meet local genetic data rules |
Physician Insight & Safety Protocol
“Clinical correlation with porphyrin biochemistry is essential; a negative UROD gene test does not exclude acquired PCT due to somatic mutations or environmental triggers. Always interpret results alongside family history, iron studies, and liver function. Patient education on strict alcohol and oestrogen avoidance remains paramount.” — Dr. PRABHAKAR REDDY, DHA Licence No. 61713011, Senior Clinical Geneticist.
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Certain drugs (e.g., barbiturates, sulphonamides, oral contraceptives) may exacerbate PCT; however, the UROD test does not require medication changes unless specifically advised by your physician.
🛑 Exclusion Criteria & Emergency Red Flags
- The test cannot be performed on patients who have received a bone marrow transplant within the past 90 days (donor DNA contamination).
- Inadequate sample volume or prolonged ambient storage invalidates results.
- Seek immediate medical attention if you develop severe blistering, skin fragility, or acute abdominal pain with photosensitivity — these may indicate acute porphyria crisis and require urgent care, irrespective of genetic test status.
Patient FAQ & Clinical Guidance
1. How does the UROD gene NGS test confirm familial porphyria cutanea tarda?
This identifies pathogenic single‑nucleotide variants, small deletions/duplications in the UROD gene, establishing a definitive genetic diagnosis of familial PCT. Snippet: يؤكد تحليل جين UROD عبر التسلسل الجيني الكامل طفراتٍ ممرضةً تسبب البورفيريا الجلدية الآجلة العائلية بنسبة دقة 99.9%.
2. What sample types are accepted and how is the home collection performed in Dubai?
We accept whole blood (EDTA), extracted DNA, or a single blood drop on an FTA card; a DHA‑certified phlebotomist arrives at your location between 8 AM‑11 PM with cold‑chain transport. يُقبل عينة دم كامل أو حمض نووي مستخلص أو قطرة دم على بطاقة FTA مع سحب منزلي معتمد من هيئة الصحة بدبي ونقل مبرَّد ISO.
3. Will a negative UROD genetic result rule out PCT?
No — a negative result does not exclude acquired (type I) PCT or somatic mutations, so clinical and biochemical follow‑up is always indicated. النتيجة السلبية لا تستبعد البورفيريا الجلدية المكتسبة؛ لذا تظل المتابعة السريرية والكيموحيوية ضرورية.
UAE Regulatory Compliance & Accreditation
- Federal Decree‑Law No. 41 of 2024 – Human Genomics Regulation, Article 87: Informed consent for genetic testing and data confidentiality.
- CDS Law 2026 – Minors require parental/guardian consent; results communicated through genetic counselling.
- UAE PDPL (Data Privacy Law) – All genomic data stored on‑shore, encrypted, and never shared without explicit consent.
- ISO 9001:2015 Certified – Certificate No. INT/EGQ/2509DA/3139; Facility Licence: 9834453.
- Tests are processed in CAP‑accredited, DHA‑licensed laboratories using Illumina NGS platforms, validated for diagnostic use under MOHAP guidelines.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians